Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells.
Zinzani
P L
PL
Martinelli
G
G
Buzzi
M
M
Farabegoli
P
P
Bendandi
M
M
Tura
S
S
D015762:2-Chloroadenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D003839:Deoxyadenosines / Q000494:pharmacology*; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology*; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000473:pathology; D015649:Pentostatin / Q000494:pharmacology*; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000494:pharmacology
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D003839:Deoxyadenosines; D016898:Interferon-alpha; D015762:2-Chloroadenosine; D015649:Pentostatin; D014740:Vidarabine; C055994:2-chloro-3'-deoxyadenosine; C024352:fludarabine